Aetion will use this fresh funding to further innovate its platform, expand its footprint in Europe and Asia, and grow its team to keep up with a surge in demand. The company is now hiring, with dozens of open positions at its NYC HQ and offices in Boston and LA.
This latest funding round comes about a year after ElevateBio announced a $170 million Series B. The money will be used to expand its R&D and manufacturing capabilities, and spin out new companies and partnerships based on that research.
